Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001209191-22-007311

Options or other derivatives

  • CBFO acquired 218,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rona Jeffrey A CBFO 2022-02-03 Grant or award · Stock Option (Right to Buy) +218,750 218,750 D
Loading xslF345X03/doc4.xml…